Prostate cancer screening- public consultation

The UK National Screening Committee (UK NSC) has opened a public consultation on prostate cancer screening. It is consulting on its 2025 review of updated evidence and a draft updated recommendation. 

The LabMed Scientific Affairs and Clinical Practice Committee (SACP) will be submitting a response, but members can submit an individual response here: https://nationalscreening.blog.gov.uk/2025/11/28/uk-nsc-opens-consultation-on-draft-prostate-cancer-screening-recommendation/

The UK NSC’s draft recommendation is to:

  • offer a targeted national prostate cancer screening programme to men with confirmed BRCA1 or BRCA2 gene variants every 2 years, from age 45 to age 61
  • not recommend population screening
  • not recommend targeted screening of Black men
  • not recommend targeted screening of men with family history
  • collaborate with the Transform screening research trial team to:
    • answer outstanding questions on screening effectiveness for black men and men with a family history – as soon as trial data becomes available
    • await results of the study to develop and trial a more accurate test than PSA alone, to improve the balance of benefit and harm of screening

The deadline for responses is 11.59pm GMT on Friday 20 February 2026.